Professional Documents
Culture Documents
The Beck Cognitive Insight Scale (BCIS) .BCIS was developed to evaluate patients selfreflectiveness and their overconfidence in their interpretations of their experiences. It consists of
a 15-item self-report questionnaire, a 9-item self- reflectiveness subscale, and a 6-item selfcertainty subscale. The first component consisted of 9 items measuring objec- tivity
reflectiveness and openness to feedback and has given the label self-reflectiveness. Under the
umbrella of decision- making and resistance to feedback, 6 items were united in a second
component of the scale, labeled self-certainty. High scores on the subscale self-reflectiveness
and low scores on subscale self-certainty are considered as normal. A composite index of the
BCIS reflecting cognitive insight was calculated by subtracting the score for the self-certainty
scale from that of the self-reflectiveness scale; a score of 10 points or more signifies good
cognitive insight. Respondents are asked to rate how much they agree with each statement by
using a 4- point scale that ranges from 0 (do not agree at all) to 3 (agree completely). No time
frame for the ratings is provided. The coefficient for the self-reflectiveness scale was 0.68 and
for self-certainty was 0.60 for the original sample.
POSITIVE AND NEGATIVE SYMPTOM SCALE
The studies on which these analyses are based were selected because of their inclusion of the
PANSS and its subscales among their primary and secondary measures of efficacy. The PANSS
is an assessment tool that measures the severity of the psychiatric symptoms of psychosis. It
consists of 30 items, each rated on a scale from 1, absent, to 7, extreme (range, 30-210).
Since the time that the PANSS was introduced, based on the original 2 symptomatic dimensions
of schizophrenia, positive and negative, several alternative sets of subscales have been proposed
based on power analysis of specific symptom clusters [17,26,27]. The current set of analyses, in
addition to assessing changes in PANSS total scores, simultaneously examines changes in the5
dimensions proposed by Davis and Chen [28]: positive (positive symptoms, items 1-3, 5, 6, 14,
23, 26, and 29); negative (negative symptoms, items 8-11, 13, 21, and 30); disorganized thought
(items 12, 18, 19, 24, 25, and 27); hostility, which includes symptoms of excitement and
impulsivity (items 4, 7, 22, and 28); and depressive, which includes symptoms of anxiety (items
15-17 and 20). The PANSS measurements were obtained from the time points that were common
to all 5 source studies, at randomization and after 2, 4, 6, 8, 16, 20, and 24 weeks of treatment.